| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Retrospective Cohort Study |
| Article Title |
Trends in medication use and treatment patterns in Chinese patients with inflammatory bowel disease
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Ling-Ya Yao, Bu-Le Shao, Feng Tian, Mei Ye, Yu-Qin Li, Xiao-Lei Wang, Lin Wang, Shao-Qi Yang, Xiao-Ping Lv, Yan Jia, Xue-Hong Wang, Xiao-Qi Zhang, Yan-Ling Wei and Qian Cao |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Qian Cao, PhD, Chief Doctor, Chief Physician, Department of Gastroenterology, Sir Run Run Shaw Hospital, College of Medicine Zhejiang University, No. 3 East Qingchun Road, Shangcheng District, Hangzhou 310016, Zhejiang Province, China. caoq@zju.edu.cn |
| Key Words |
Inflammatory bowel disease; Crohn's disease; Ulcerative colitis; Medication trends; Treatment pattern; Infliximab |
| Core Tip |
Prescriptions of immunosuppressants and infliximab (IFX) increased in parallel with steady or decreasing prescriptions of 5-aminosalicylates and corticosteroids in Chinese patients with inflammatory bowel disease. Furthermore, a switching profile from conventional drugs to IFX was observed in patients with Crohn's disease. This is the first multicenter cohort study to depict temporal trends in long-term medication uses and periodic changes in treatment paradigms in the Chinese population, which may provide evidence for clinical practice in the foreseeable future. |
| Publish Date |
2022-08-10 08:23 |
| Citation |
Yao LY, Shao BL, Tian F, Ye M, Li YQ, Wang XL, Wang L, Yang SQ, Lv XP, Jia Y, Wang XH, Zhang XQ, Wei YL, Cao Q. Trends in medication use and treatment patterns in Chinese patients with inflammatory bowel disease. World J Gastroenterol 2022; 28(30): 4102-4119 |
| URL |
https://www.wjgnet.com/1007-9327/full/v28/i30/4102.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v28.i30.4102 |
